Synapse Open Synapse
Biology

Viking shares surge on updated obesity drug data

BioPharma Dive · · 2 min read

Trial participants mostly kept their weight down after switching from a weekly shot to less frequent dosing — findings that could strengthen Viking’s “competitive positioning,” one analyst wrote.

Latest from BioPharma Dive